ISRCTN90051516已完成未知
Modification of vascular disease markers in active rheumatoid arthritis with fully human monoclonal anti-TNF-alpha antibody (Humira® [adalimumab])
Guy's and St Thomas' NHS Foundation Trust (UK)0 个研究点目标入组 24 人开始时间: 2008年2月14日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •1. Subjects who fulfill the British Society of Rheumatology guidelines for TNF blocking therapy in Rheumatoid Arthritis (RA)
- •2. Subjects who have abnormal vascular function as assessed at the screening visit
- •3. Men and women >= 18 years of age, with RA as defined by the 1987-revised merican College of Rheumatology (ACR) diagnostic criteria, with a Disease Activity Score (DAS) greater than 5.1
- •4. Men and women of childbearing potential must use adequate birth control measures (e.g., abstinence, oral contraceptives, intrauterine device, barrier method with spermicide, or surgical sterilization) for the duration of the study
- •5. Patient must be able to adhere to the study visit schedule
- •6. The patient must be capable of giving informed consent and the consent must be obtained prior to any screening procedures
- •7. Must have a chest X-ray within 3 months prior to commencement of adalimumab with no evidence of malignancy, infection or fibrosis
排除标准
- •1. Women who are pregnant or breast feeding.
- •2. Use of any investigational drug within 1 month prior to screening or within 5 half-lives of the investigational agent, whichever is longer.
- •3. Treatment with any other therapeutic agent targeted at reducing TNF (e.g., pentoxifylline, thalidomide, etanercept, etc.) within 3 months of screening.
- •4. History of diabetes mellitus.
- •5. History of ischemic heart disease or peripheral vascular disease.
- •6. Serious infections (such as pneumonia or pyelonephritis) in the previous 3 months. Less serious infections (such as acute upper respiratory tract infection [colds] or simple urinary tract infection) need not be considered exclusions at the discretion of the investigator.
- •7. Have active TB or have evidence of latent TB (old or latent TB on chest x-ray, without adequate therapy for TB initiated prior to first dose of study drug). Also excluded are patients with evidence of an old or latent TB infection without documented adequate therapy. Patients with a current close contact with an individual with active TB and patients who have completed treatment for active TB within the previous 2 years are explicitly excluded from the trial. Patients with a household member who has a history of active pulmonary TB should have had a thorough evaluation for TB prior to study enrollment as recommended by a local infectious disease specialist or published local guidelines of TB control agencies.
- •8. Presence of a transplanted organ (with the exception of a corneal transplant >3 months prior to screening).
- •9. Malignancy within the past 5 years (except for squamous or basal cell carcinoma of the skin that has been treated with no evidence of recurrence).
- •10. History of lymphoproliferative disease including lymphoma, or signs and symptoms suggestive of possible lymphoproliferative disease, such as lymphadenopathy of unusual size or location (such as nodes in the posterior triangle of the neck, infra-clavicular, epitrochlear, or periaortic areas), or splenomegaly.
- •11. Known recent substance abuse (drug or alcohol).
- •12. Poor tolerability of venepuncture required for blood sampling during the study period.
研究者
相似试验
招募中
不适用
The study of biomarkers for intractable vascular anomalies and associated with pharmacological action of sirolimusVascular anomaliesJPRN-UMIN000029173Gifu University50
尚未招募
不适用
Development of risk indicators for vascular diseases with multi-omics and non-invasive blood flow analysis1.Diabetes and its complications 2.Vascular diseasesJPRN-UMIN000039800Tohoku University7,000
已完成
不适用
Relevance of Vascular Function Markers: Study on the Effects of Quercetin and Epicatechin on Blood Pressure and Vascular Function in (Pre)Hypertensive SubjectsHigh blood pressurevascular function10057166NL-OMON39481TI Food and Nutrition40
招募中
不适用
The relation between inflammation cells and immune-system cells and the development of hardening of the arteries (arteriosclerosis), a research project with MRI in young adultsdevelopment of subclinical arteriosclerosis in the young de ontwikkeling van subklinische atherosclerose in jonge volwassenenNL-OMON27711niversity Medical Center Utrecht520
已完成
不适用
Biomarkers and cardiovascular risk in disease models of non-alcoholic fatty liver diseasefatty liverNL-OMON48654Medisch Universitair Ziekenhuis Maastricht85